Quality Care India Limited (QCIL) engaged in healthcare business and related services through a network of multi-specialty healthcare establishments across India and Bangladesh that it or its subsidiaries own or operate from time to time. Its standalone turnover was Rs 1,136.33 crore in FY24. Ahead of this merger, Aster shall purchase 5% stake or 1,90,46,028 crore shares at Rs 445.8 per share in QCIL from Blackstone and TPG in consideration of primary share issuance by Aster for 3.6% stake or 1,86,07,969 crore equity shares at Rs 456.33 per share. The acquisition will require an in-principle approval of the stock exchanges and the approval of the Competition Commission of India (CCIL) and it will be completed within 15 days from date of the shareholder approval or the date of the CCI approval (whichever is later). The merged listed entity will be named Aster DM Quality Care Limited. Aster DM Quality Care Limited will have a combined portfolio of four leading brands, Aster DM, CARE Hospitals, KIMSHEALTH and Evercare. The combined entity will have a of network of 38 hospitals and more than 10,150 beds spread across 27 cities making it one of the top 3 hospital chains in India. The merger will create a top-3 hospital chain in India, with a strong presence in South and Central India. The combined entity will benefit from a well-diversified network across 9 states, minimal geographic overlap, and a comprehensive healthcare ecosystem encompassing hospitals, labs, clinics, and pharmacies. This strategic combination is expected to unlock significant synergies in revenue, procurement, & supply chain, capex, and integration of corporate functions. Leveraging its strong clinical capabilities, the merged entity is well-positioned for future growth. A robust expansion plan for both brownfield and greenfield is underway, targeting the addition of 3,500 new beds between FY24 and FY27. The transaction is subject to shareholder & regulatory approvals, and other customary conditions to closing. Aster expects the merger transaction to close by Q3 FY26. The ratio for the initial share acquisition is the same as proposed for the merger. Subject to necessary approvals, Aster Promoters and Blackstone will hold equal representation on the board and jointly oversee the merged entity, Dr. Azad Moopen will continue as the executive chairman of the merged entity, Varun Khanna and Sunil Kumar will be promoted to the position of MD & group chief executive officer and group chief financial officer of the merged entity respectively. Aster is valued at a multiple of 36.6x on FY24 adjusted post IND AS EV/ EBITDA. In comparison, QCIL is valued at a multiple of 25.2x based on FY24 adjusted post IND AS EV/ EBITDA. Based on the swap ratio recommended in the valuation report, the resultant shareholding of the Merged Entity will be 24.0% and 30.7% held by Aster Promoters and Blackstone respectively, with the balance 45.3% being held by public and other shareholders. Azad Moopen, founder and chairman of Aster DM Healthcare, said, 'The new combined entity 'Aster DM Quality Care Ltd.' is poised to become one of the largest healthcare players in the industry, setting new benchmarks in patient-centric care, innovation, and accessibility. The Moopen family who has been instrumental in managing Aster's India and GCC businesses will also lead the new merged entity. Thus, by combining the strengths of two pioneers, we are not only expanding our footprint but also creating a transformative force capable of reshaping the healthcare landscape. The integration of Aster and Quality Care's extensive network and deep operational expertise with backing from Blackstone and TPG ' among the most respected private equity firms will enhance our ability to deliver world-class healthcare services, drive innovation, and improve patient outcomes. The merger will also provide our medical professionals with an opportunity to cater to higher and diverse patient inflows.' Varun Khanna, group managing director of Quality Care, said, 'This merger demonstrates our aligned cultures and value systems, and furthers our commitment to address bed shortage in India's underserved regions. The teams at Aster and Quality Care have established a strong legacy of positively impacting patients' lives and meeting the evolving needs of communities. I look forward to leading this platform into a new era focused on healthcare excellence and serving the best interests of the patients.' Aster DM Healthcare is primarily involved in the operations of healthcare facilities, retail pharmacies, and providing consultancy in areas relating to healthcare. The company reported consolidated net profit of Rs 96.84 crore in Q2 FY25 as compared with net loss of Rs 30.80 crore posted in Q2 FY24. Revenue from operations jumped 16.89% year on year (YoY) to Rs 1,086.44 crore during the quarter ended 30 September 2024. The counter added 2.35% to end at Rs 499.95 on Friday, 29 November 2024.Powered by Capital Market - Live

Quality Care India Limited (QCIL) engaged in healthcare business and related services through a network of multi-specialty healthcare establishments across India and Bangladesh that it or its subsidiaries own or operate from time to time. Its standalone turnover was Rs 1,136.33 crore in FY24. Ahead of this merger, Aster shall purchase 5% stake or 1,90,46,028 crore shares at Rs 445.8 per share in QCIL from Blackstone and TPG in consideration of primary share issuance by Aster for 3.6% stake or 1,86,07,969 crore equity shares at Rs 456.33 per share. The acquisition will require an in-principle approval of the stock exchanges and the approval of the Competition Commission of India (CCIL) and it will be completed within 15 days from date of the shareholder approval or the date of the CCI approval (whichever is later). The merged listed entity will be named Aster DM Quality Care Limited. Aster DM Quality Care Limited will have a combined portfolio of four leading brands, Aster DM, CARE Hospitals, KIMSHEALTH and Evercare. The combined entity will have a of network of 38 hospitals and more than 10,150 beds spread across 27 cities making it one of the top 3 hospital chains in India. The merger will create a top-3 hospital chain in India, with a strong presence in South and Central India. The combined entity will benefit from a well-diversified network across 9 states, minimal geographic overlap, and a comprehensive healthcare ecosystem encompassing hospitals, labs, clinics, and pharmacies. This strategic combination is expected to unlock significant synergies in revenue, procurement, & supply chain, capex, and integration of corporate functions. Leveraging its strong clinical capabilities, the merged entity is well-positioned for future growth. A robust expansion plan for both brownfield and greenfield is underway, targeting the addition of 3,500 new beds between FY24 and FY27. The transaction is subject to shareholder & regulatory approvals, and other customary conditions to closing. Aster expects the merger transaction to close by Q3 FY26. The ratio for the initial share acquisition is the same as proposed for the merger. Subject to necessary approvals, Aster Promoters and Blackstone will hold equal representation on the board and jointly oversee the merged entity, Dr. Azad Moopen will continue as the executive chairman of the merged entity, Varun Khanna and Sunil Kumar will be promoted to the position of MD & group chief executive officer and group chief financial officer of the merged entity respectively. Aster is valued at a multiple of 36.6x on FY24 adjusted post IND AS EV/ EBITDA. In comparison, QCIL is valued at a multiple of 25.2x based on FY24 adjusted post IND AS EV/ EBITDA. Based on the swap ratio recommended in the valuation report, the resultant shareholding of the Merged Entity will be 24.0% and 30.7% held by Aster Promoters and Blackstone respectively, with the balance 45.3% being held by public and other shareholders. Azad Moopen, founder and chairman of Aster DM Healthcare, said, 'The new combined entity 'Aster DM Quality Care Ltd.' is poised to become one of the largest healthcare players in the industry, setting new benchmarks in patient-centric care, innovation, and accessibility. The Moopen family who has been instrumental in managing Aster's India and GCC businesses will also lead the new merged entity. Thus, by combining the strengths of two pioneers, we are not only expanding our footprint but also creating a transformative force capable of reshaping the healthcare landscape. The integration of Aster and Quality Care's extensive network and deep operational expertise with backing from Blackstone and TPG ' among the most respected private equity firms will enhance our ability to deliver world-class healthcare services, drive innovation, and improve patient outcomes. The merger will also provide our medical professionals with an opportunity to cater to higher and diverse patient inflows.' Varun Khanna, group managing director of Quality Care, said, 'This merger demonstrates our aligned cultures and value systems, and furthers our commitment to address bed shortage in India's underserved regions. The teams at Aster and Quality Care have established a strong legacy of positively impacting patients' lives and meeting the evolving needs of communities. I look forward to leading this platform into a new era focused on healthcare excellence and serving the best interests of the patients.' Aster DM Healthcare is primarily involved in the operations of healthcare facilities, retail pharmacies, and providing consultancy in areas relating to healthcare. The company reported consolidated net profit of Rs 96.84 crore in Q2 FY25 as compared with net loss of Rs 30.80 crore posted in Q2 FY24. Revenue from operations jumped 16.89% year on year (YoY) to Rs 1,086.44 crore during the quarter ended 30 September 2024. The counter added 2.35% to end at Rs 499.95 on Friday, 29 November 2024.Powered by Capital Market - Live

Aster DM Healthcare and Quality Care India backed by Blackstone and TPG, one of the largest privately held hospital chains in India with a focus on emerging cities, have today signed definitive agreements for a merger. The merger has been approved by the Board of Directors of the respective companies and is subject to regulatory, corporate and shareholders' approvals. The merged listed entity will be named Aster DM Quality Care. Aster DM Quality Care will have a combined portfolio of four leading brands: Aster DM, CARE Hospitals, KIMSHEALTH and Evercare. The combined entity will have a of network of 38 hospitals and 10,150+ beds spread across 27 cities making it one of the top 3 hospital chains in India. Aster is valued at a multiple of 36.6x on FY24 adjusted post IND AS EV/ EBITDA. In comparison, QCIL is valued at a multiple of 25.2x based on FY24 adjusted post IND AS EV/ EBITDA. Based on the swap ratio recommended in the valuation report, the resultant shareholding of the Merged Entity will be 24.0% and 30.7% held by Aster Promoters and Blackstone respectively, with the balance 45.3% being held by public and other shareholders. Ahead of this merger, Aster shall purchase 5.0% stake in QCIL from Blackstone and TPG in consideration of primary share issuance by Aster for 3.6% stake (Initial Share Acquisition). Post the Initial Share Acquisition, QCIL will be merged into Aster by way of a scheme of amalgamation. The transaction is subject to shareholder & regulatory approvals, and other customary conditions to closing. Aster expects the merger transaction to close by Q3 FY26. The ratio for the Initial Share Acquisition is the same as proposed for the merger. Powered by Capital Market - Live

Aster DM Healthcare will hold a meeting of the Board of Directors of the Company on 29 November 2024Powered by Capital Market - Live

The domestic equity benchmarks traded near the flatline with some negative bias in morning trade. The Nifty traded below the 24,200 level. Auto shares advanced after declining in the previous trading session. At 10:30 ST, the barometer index, the S&P BSE Sensex was down 25.75 points or 0.03% to 79,978.31. The Nifty 50 index lost 10.30 points or 0.04% to 24,184.20. In the broader market, the S&P BSE Mid-Cap index rose 0.04% and the S&P BSE Small-Cap index added 0.64%. The market breadth was strong. On the BSE, 2,324 shares rose and 1,221 shares fell. A total of 165 shares were unchanged. New Listing: Shares of NTPC Green Energy were currently trading at Rs 119.85 at 10:14 IST on the BSE, representing a premium of 10.97% as compared with the issue price of Rs 108. The scrip was listed at Rs 111.60, exhibiting a premium of 3.33% to the issue price. So far, the stock has hit a high of 119.90 and a low of 111.60. On the BSE, over 125.44 lakh shares of the company were traded in the counter so far. Buzzing Index: The Nifty Auto index rose 0.39% to 23,504.75. The index fell 1.07% in the previous trading session. Exide Industries (up 1.86%), Mahindra & Mahindra (up 1.07%), Ashok Leyland (up 0.84%), Maruti Suzuki India (up 0.83%) and Bajaj Auto (up 0.8%), Tata Motors (up 0.7%) added. On the other hand, Apollo Tyres (down 1.62%), Balkrishna Industries (down 0.96%) and Samvardhana Motherson International (down 0.77%) turned lower. Stocks in Spotlight: Aster DM Healthcare gained 3.55% after the company entered into an agreement with Aster Adhaar Hospital (Prerana Hospital) to acquire an additional 13% stake in Aster Adhaar Hospital (Prerana Hospital) in Kolhapur, Maharashtra. CG Power and Industrial Solutions added 2.07% after the company's subsidiary G.G.Tronics India (GGT) secured a KAVACH order from Chittaranjan Locomotive Works, West Bengal, Government of India. Glenmark Pharmaceuticals shed 0.34%. The company has announced that its US-based subsidiary, Glenmark Pharmaceuticals Inc., USA, has launched Travoprost Ophthalmic Solution USP (Ionic Buffered Solution) in the U.S. market. Powered by Capital Market - Live

The 254-bedded Aster Aadhar Hospital, Kolhapur is the city's most comprehensive multi-speciality hospital. With 25+ specialties offered along with a panel of leading doctors and dedicated support staff, the hospital puts compassionate, quality care at the forefront. Its turnover was Rs 120.56 crore in FY24. Post completion of acquisition, Aster Aadhar will become wholly owned subsidiary of the company. The company will own 100% stake in Aster Aadhar from 87% stake it previously held. The said transaction will be completed in two tranches and the indicative time period for completion of the acquisition is December 31, 2025. The company said that it is well-positioned to meet the increasing demand for advanced healthcare in India. Over the next 5 years i.e. FY25-FY29, the India business is set to achieve revenue CAGR ~18% - 20% YoY growth driven by an increased occupancy and addition of capacity. The Operating EBITDA margin is expected to reach a level of ~23%-25% over the next 4-5 years. Aster DM Healthcare is primarily involved in the operations of healthcare facilities, retail pharmacies, and providing consultancy in areas relating to healthcare. The company reported consolidated net profit of Rs 96.84 crore in Q2 FY25 as compared with net loss of Rs 30.80 crore posted in Q2 FY24. Revenue from operations jumped 16.89% year on year (YoY) to Rs 1,086.44 crore during the quarter ended 30 September 2024.Powered by Capital Market - Live

Piramal Pharma Ltd, KPIT Technologies Ltd, Sona BLW Precision Forgings Ltd, Escorts Kubota Ltd are among the other stocks to see a surge in volumes on NSE today, 24 October 2024.Aster DM Healthcare Ltd recorded volume of 196.3 lakh shares by 14:14 IST on NSE, a 31.74 times surge over two-week average daily volume of 6.18 lakh shares. The stock gained 9.81% to Rs.441.45. Volumes stood at 7.02 lakh shares in the last session.Piramal Pharma Ltd recorded volume of 822.13 lakh shares by 14:14 IST on NSE, a 15.06 times surge over two-week average daily volume of 54.61 lakh shares. The stock gained 18.95% to Rs.259.29. Volumes stood at 40.12 lakh shares in the last session.KPIT Technologies Ltd registered volume of 90.02 lakh shares by 14:14 IST on NSE, a 12.91 fold spurt over two-week average daily volume of 6.98 lakh shares. The stock slipped 13.60% to Rs.1,412.20. Volumes stood at 17.35 lakh shares in the last session.Sona BLW Precision Forgings Ltd registered volume of 236.63 lakh shares by 14:14 IST on NSE, a 12.74 fold spurt over two-week average daily volume of 18.57 lakh shares. The stock rose 13.95% to Rs.733.95. Volumes stood at 16.11 lakh shares in the last session.Escorts Kubota Ltd recorded volume of 13.86 lakh shares by 14:14 IST on NSE, a 8.15 times surge over two-week average daily volume of 1.70 lakh shares. The stock lost 6.24% to Rs.3,470.35. Volumes stood at 2.03 lakh shares in the last session.Powered by Capital Market - Live

Escorts Kubota Ltd, Sona BLW Precision Forgings Ltd, AIA Engineering Ltd, V I P Industries Ltd are among the other stocks to see a surge in volumes on BSE today, 24 October 2024.Aster DM Healthcare Ltd recorded volume of 6.07 lakh shares by 10:47 IST on BSE, a 18.87 times surge over two-week average daily volume of 32194 shares. The stock gained 9.13% to Rs.439.05. Volumes stood at 53232 shares in the last session.Escorts Kubota Ltd clocked volume of 37588 shares by 10:47 IST on BSE, a 8.57 times surge over two-week average daily volume of 4387 shares. The stock lost 6.09% to Rs.3,477.15. Volumes stood at 9297 shares in the last session.Sona BLW Precision Forgings Ltd witnessed volume of 2.35 lakh shares by 10:47 IST on BSE, a 7.79 times surge over two-week average daily volume of 30138 shares. The stock increased 10.19% to Rs.707.90. Volumes stood at 42437 shares in the last session.AIA Engineering Ltd registered volume of 5225 shares by 10:47 IST on BSE, a 4.38 fold spurt over two-week average daily volume of 1194 shares. The stock slipped 1.48% to Rs.3,904.95. Volumes stood at 2060 shares in the last session.V I P Industries Ltd witnessed volume of 86948 shares by 10:47 IST on BSE, a 4.01 times surge over two-week average daily volume of 21664 shares. The stock dropped 4.73% to Rs.484.90. Volumes stood at 42485 shares in the last session.Powered by Capital Market - Live

Aster DM Healthcare Ltd gained 9.62% today to trade at Rs 441. The BSE Healthcare index is up 0.57% to quote at 42951.47. The index is down 2.89 % over last one month. Among the other constituents of the index, Piramal Pharma Ltd increased 4.29% and Supriya Lifescience Ltd added 3.3% on the day. The BSE Healthcare index went up 57.23 % over last one year compared to the 25.22% surge in benchmark SENSEX. Aster DM Healthcare Ltd has added 4.64% over last one month compared to 2.89% fall in BSE Healthcare index and 5.55% drop in the SENSEX. On the BSE, 70859 shares were traded in the counter so far compared with average daily volumes of 38642 shares in the past one month. The stock hit a record high of Rs 558.3 on 15 Apr 2024. The stock hit a 52-week low of Rs 312.25 on 04 Jun 2024.Powered by Capital Market - Live

Net profit of Aster DM Healthcare reported to Rs 96.84 crore in the quarter ended September 2024 as against net loss of Rs 30.79 crore during the previous quarter ended September 2023. Sales rose 16.89% to Rs 1086.44 crore in the quarter ended September 2024 as against Rs 929.43 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1086.44929.43 17 OPM %19.9915.29 - PBDT220.92115.69 91 PBT158.6561.27 159 NP96.84-30.79 LP Powered by Capital Market - Live